Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
04. June 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16482
Articles 1 - 20 / 329627
Comparative efficacy of exercise modes on inflammatory cytokines in patients with breast cancer: a systematic review with pairwise and network meta-analyses.
Sci Rep
Khalafi M, Sakhaei MH, Ghasemi F, Fatolahi S, Omidian K, Symonds ME, Rohani H, Rosenkranz SK, Suzuki K, Zakeri AS, Mohammadiyan M, Mojtahedi S, Maleki AH, Rafiei H.
PMID: 42236844 [PubMed - as supplied by publisher]
Breast cancer in Bosnia and Herzegovina: real-world patterns of diagnosis, treatment, and survival outcomes.
Sci Rep
Be, Sokolovi, Ceri, Pa, Grebo A, Alji, Mattar L, Freedman C, Doroshenko O, Mandrik O.
PMID: 42236771 [PubMed - as supplied by publisher]
Providers' perspectives on implementing alert-based patient-reported outcome monitoring for stage IV breast cancer.
J Patient Rep Outcomes
Breidenbach C, Hage AM, Schellack SK, Pross T, Dordevic AD, Kowalski C, Karsten MM.
PMID: 42236639 [PubMed - as supplied by publisher]
Combining Node-RADS with ADC can improve diagnostic performance for lymph node metastasis in breast cancer.
Eur Radiol
Han L, Jia N, Wang H, Zhang W, Luo Y, Huang B, Liu G, Ye D, Wang X, Dong Y.
PMID: 42236540 [PubMed - as supplied by publisher]
Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies.
BJC Rep
Allen I, Whish N, Yadav S, Boddicker NJ, Drukker C, van de Beek I, Eccles DM, Turnbull C, Pharoah P, Antoniou AC, Easton DF, Couch FJ, Schmidt MK, Tischkowitz M.
PMID: 42236538 [PubMed]
Is molecular breast imaging suitable for use in UK breast cancer pathways? A qualitative study exploring healthcare professionals' perspectives.
BMJ Open
Elliott H, Allen AJ, Forester ND, Graziadio S, Jones WS, Lendrem C, Pearce M, Powell T, Bray A, Scott J.
PMID: 42236092 [PubMed - in process]
Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.
Obstet Gynecol Clin North Am
Tewari S, Hall MF.
PMID: 42236072 [PubMed - in process]
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes.
Cancer Treat Rev
Jacobs F, Polymeropoulos A, Monte M, Ligorio F, Provenzano L, Armani G, Fotia G, Mazzoli G, Coppola G, Bottelli A, Iacobucci A, Bianchessi V, Abate A, Bianchi GV, Capri G, Ferraris C, Martelli G, Folli S, Vingiani A, Pruneri G, Miceli R, Vernieri C.
PMID: 42235455 [PubMed - as supplied by publisher]
Genomic instability in canine mammary tumors: A comparative focus on loss of heterozygosity and microsatellite alterations with human breast cancer.
Mutat Res Rev Mutat Res
Khand FM, Jatoi BA, Lakho SA, Leghari A.
PMID: 42235400 [PubMed - as supplied by publisher]
Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.
Int J Gynecol Cancer
Nolin A, Brown MD, Thomas SM, Strickland KC, Bean S, Neff JL, Pothuri B, Moore KN, Mullen M, Clark LH, Konecny G, Jackson AL, Ko EM, Whitaker R, Linhart S, March L, Hacker K, Washington C, Thaker P, Maxwell GL, Berchuck A, Secord AA, Previs RA.
PMID: 42235254 [PubMed - as supplied by publisher]
Self-managed non-pharmacological interventions for post-treatment upper limb dysfunction rehabilition among breast cancer survivors: A systematic review.
Eur J Oncol Nurs
Li J, Tan JB, Wang T, Wang H, Li M, Sharma S, Deravin L, Terry D.
PMID: 42235206 [PubMed - as supplied by publisher]
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong.
Breast
Abudureheiyimu N, Jia Y, Peng Z, Shi Y, Liu Q, Wang H, Zhou Y, Wang H, Wang K, Hu H, Liu Z, Chen W, Ng TY, Guo Z, Ren Z, Zhen H, Fan Y, Xu B.
PMID: 42235181 [PubMed - as supplied by publisher]
A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case-control pilot study.
Breast
Generali D, Membrino A, Fontana A, Gattazzo F, Strina C, Milani M, Cervoni V, Caltavituro A, Castagnetti A, Del Bianco S, Schettini F.
PMID: 42235180 [PubMed - as supplied by publisher]
Deep learning-based prediction of homologous recombination deficiency from histopathological whole-slide images in ovarian cancer.
Int J Gynecol Cancer
Frenel JS, Heudel PE, Guinaudeau E, Bossard C, Lindahl G, Rynkiewicz J, Salhi S, Salhi Y, Chetritt J, Pujade-Lauraine E, Ray-Coquard I.
PMID: 42235122 [PubMed - as supplied by publisher]
The effect of vaginal tamoxifen on symptoms of anxiety, depression, and health-related quality of life in postmenopausal women with and without breast cancer.
Maturitas
Yazici Sarikaya S, Nyback S, Derntl B, Ljungman L, Hirschberg AL, Kopp Kallner H, Sundström Poromaa I, Wikman A, Kunovac Kallak T.
PMID: 42235095 [PubMed - as supplied by publisher]
Association between long-term exposure to ambient air pollution and breast cancer risk in Mexico: a systematic review of observational studies.
J Environ Sci Health C Toxicol Carcinog
Villa-Guillen DE, Villa-Carrillo JA.
PMID: 42234769 [PubMed - as supplied by publisher]
Biomarker-driven and AI-assisted nanomedicine for breast cancer: advancing precision drug delivery from bench to bedside.
Expert Opin Drug Deliv
Barar J, Ansari R, Omidi Y.
PMID: 42234571 [PubMed - as supplied by publisher]
Expression of adenosine A1, A2A, A2B, and A3 receptors in ovarian cancer: their clinical potential in diagnosis and prognosis.
Mol Biol Rep
Azizi L, Babaei Z, Keyvanloo Shahrestanaki M, Soltani S, Panjehpour M, Aghaei M.
PMID: 42234312 [PubMed - in process]
Mechanisms of breast cancer dormancy in bone metastasis.
Clin Exp Metastasis
Price ML, Zhou J, Le Maitre CL, Quayle LA, Ottewell PD.
PMID: 42234001 [PubMed - in process]
Impact of nanocarrier mediated drug delivery systems: a deep dive into therapeutics and clinical management of breast cancer.
Nanomedicine (Lond)
Hanif S, Shahid N, Iqbal J, Yasir S, Arfat Idrees H, Farooq MI, Rai N, Ali Syed M, Noreen S.
PMID: 42233624 [PubMed - as supplied by publisher]
Articles 1 - 20 / 329627
Page 1 of 16482
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy